MARY HERNANDEZ: Open Payments
NPI 1952728867 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$564 in 21 payments from 9 companies in 2025. Trend: 2023 $376 · 2024 $879 · 2025 $564
Food & beverage: $564
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $219 |
| Exact Sciences Corporation | 4 | $90 |
| PFIZER INC. | 3 | $63 |
| Corcept Therapeutics | 3 | $55 |
| Lilly USA, LLC | 2 | $38 |
| Novo Nordisk Inc | 1 | $31 |
| Dexcom, Inc. | 1 | $26 |
| UCB, Inc. | 1 | $25 |
| Amgen Inc. | 1 | $17 |
Products named: AIRSUPRA, FARXIGA, Cologuard Collection Kit, Korlym, NURTEC ODT, MOUNJARO, Ozempic, Dexcom G6 Transmitter.
Industry payments across TX — which companies pay providers there.
